Stark H - Search Results

1

The histamine H₄ receptor: targeting inflammatory disorders.

Walter M, Kottke T, Stark H. Walter M, et al. Among authors: stark h. Eur J Pharmacol. 2011 Oct 1;668(1-2):1-5. doi: 10.1016/j.ejphar.2011.06.029. Epub 2011 Jul 3. Eur J Pharmacol. 2011. PMID: 21741967 Review.

2

Design of histamine H3-receptor agonists and antagonists.

Schunack W, Stark H. Schunack W, et al. Among authors: stark h. Eur J Drug Metab Pharmacokinet. 1994 Jul-Sep;19(3):173-8. doi: 10.1007/BF03188918. Eur J Drug Metab Pharmacokinet. 1994. PMID: 7867658 Review.

3

Novel histamine H3 receptor antagonists: affinities in an H3 receptor binding assay and potencies in two functional H3 receptor models.

Schlicker E, Kathmann M, Reidemeister S, Stark H, Schunack W. Schlicker E, et al. Among authors: stark h. Br J Pharmacol. 1994 Aug;112(4):1043-8. doi: 10.1111/j.1476-5381.1994.tb13188.x. Br J Pharmacol. 1994. PMID: 7952862 Free PMC article.

4

Bioavailability, antinociceptive and antiinflammatory properties of BP 2-94, a histamine H3 receptor agonist prodrug.

Rouleau A, Garbarg M, Ligneau X, Mantion C, Lavie P, Advenier C, Lecomte JM, Krause M, Stark H, Schunack W, Schwartz JC. Rouleau A, et al. Among authors: stark h. J Pharmacol Exp Ther. 1997 Jun;281(3):1085-94. J Pharmacol Exp Ther. 1997. PMID: 9190840

5

Development of a binding site model for histamine H3-receptor agonists.

Sippl W, Stark H, Höltje HD. Sippl W, et al. Among authors: stark h. Pharmazie. 1998 Jul;53(7):433-7. Pharmazie. 1998. PMID: 9699219

6

Neurochemical and behavioral effects of ciproxifan, a potent histamine H3-receptor antagonist.

Ligneau X, Lin J, Vanni-Mercier G, Jouvet M, Muir JL, Ganellin CR, Stark H, Elz S, Schunack W, Schwartz J. Ligneau X, et al. Among authors: stark h. J Pharmacol Exp Ther. 1998 Nov;287(2):658-66. J Pharmacol Exp Ther. 1998. PMID: 9808693

7

Histamine H(3)-receptor antagonists inhibit gastroprotection by (R)-alpha-methylhistamine in the rat.

Morini G, Grandi D, Stark H, Schunack W. Morini G, et al. Among authors: stark h. Br J Pharmacol. 2000 Apr;129(8):1597-600. doi: 10.1038/sj.bjp.0703249. Br J Pharmacol. 2000. PMID: 10780963 Free PMC article.

8

Anti-inflammatory and antinociceptive properties of BP 2-94, a histamine H(3)-receptor agonist prodrug.

Rouleau A, Stark H, Schunack W, Schwartz JC. Rouleau A, et al. Among authors: stark h. J Pharmacol Exp Ther. 2000 Oct;295(1):219-25. J Pharmacol Exp Ther. 2000. PMID: 10991982

9

Stages of avoidance strategy formation in gerbils are correlated with dopaminergic transmission activity.

Stark H, Bischof A, Wagner T, Scheich H. Stark H, et al. Eur J Pharmacol. 2000 Sep 29;405(1-3):263-75. doi: 10.1016/s0014-2999(00)00558-6. Eur J Pharmacol. 2000. PMID: 11033333

10

Different antagonist binding properties of human and rat histamine H3 receptors.

Stark H, Sippl W, Ligneau X, Arrang JM, Ganellin CR, Schwartz JC, Schunack W. Stark H, et al. Bioorg Med Chem Lett. 2001 Apr 9;11(7):951-4. doi: 10.1016/s0960-894x(01)00090-7. Bioorg Med Chem Lett. 2001. PMID: 11294398

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results